denosumab
SpainDrugs containing this active substance
-
It is used to treat osteoporosis in postmenopausal women and in men at risk of fractures. It is also used to treat bone loss caused by reduced hormone levels in patients with prostate cancer or due to long-term glucocorticoid treatment in individuals at risk of fracture.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg Manufacturer: Reddy Holding Gmbh
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture. It is also prescribed for bone loss caused by hormone reduction (testosterone) in patients with prostate cancer or due to long-term glucocorticoid treatment in individuals at risk of fracture.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg/ml Manufacturer: Sciencepharma Sp. Z O.O.
-
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 120 mg Manufacturer: Sciencepharma Sp. Z O.O.
-
It is used in adults to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 70 mg/ml Manufacturer: Fresenius Kabi Deutschland Gmbh
-
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 70 mg/ml Manufacturer: Fresenius Kabi Deutschland Gmbh
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture, as well as bone loss caused by testosterone reduction in patients with prostate cancer or by long-term use of glucocorticoids.
Form: solution for injection
Active substance Dosage denosumab 60 mg/ml Manufacturer: Fresenius Kabi Deutschland Gmbh
-
It is used in adults to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 120 mg Manufacturer: Zentiva K.S.
-
It is used to treat postmenopausal osteoporosis in women and osteoporosis in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to prolonged glucocorticoid use in individuals at high risk of fracture.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg Manufacturer: Biosimilar Collaborations Ireland Limited
-
It is used to treat postmenopausal osteoporosis in women and osteoporosis in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to long-term glucocorticoid use in individuals at risk of fracture.
Form: solution for injection
Active substance Dosage denosumab 60 mg Manufacturer: Mabxience Research S.L.
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or by long-term glucocorticoid use in individuals at risk of fracture.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg Manufacturer: Sandoz Gmbh
-
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell tumor of the bone in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 133 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat postmenopausal osteoporosis in women and osteoporosis in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to long-term glucocorticoid use.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg/ml Manufacturer: Gedeon Richter Plc.
-
It is used to treat postmenopausal osteoporosis in women and osteoporosis in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to long-term glucocorticoid treatment.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg Manufacturer: Stada Arzneimittel Ag
-
It is used to treat postmenopausal osteoporosis in women and osteoporosis in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to prolonged glucocorticoid use.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 120 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture, bone loss due to reduced hormone levels following surgery or prostate cancer treatment, and bone loss due to long-term glucocorticoid treatment.
Form: solution for injection
Active substance Dosage denosumab 60 mg/ml Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture. It is also prescribed for bone loss caused by reduced testosterone in patients with prostate cancer or by long-term treatment with glucocorticoids.
Form: solution for injection
Active substance Dosage denosumab 60 mg/ml Manufacturer: Teva Gmbh
-
It is used to treat osteoporosis in postmenopausal women and in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or by long-term glucocorticoid use in individuals at risk of fracture.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg Manufacturer: Amgen Europe B.V.
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture. It is also prescribed for bone loss caused by reduced testosterone in patients with prostate cancer or by long-term glucocorticoid treatment in individuals at high risk of fracture.
Form: solution for injection
Active substance Dosage denosumab 60 mg Manufacturer: Sandoz Gmbh
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture, as well as bone loss caused by testosterone reduction in patients with prostate cancer or by long-term use of glucocorticoids.
Form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to long-term glucocorticoid treatment.
Form: solution for injection
Active substance Dosage denosumab 60 mg Manufacturer: Intas Third Party Sales 2005 S.L.
-
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 120 mg Manufacturer: Sandoz Gmbh
-
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 120 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used in adults to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell tumor of the bone in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 120 mg Manufacturer: Amgen Europe B.V.
-
It is used in adults to prevent serious complications caused by bone metastasis (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Form: solution for injection
Active substance Dosage denosumab 70,6 mg/ml Manufacturer: Gedeon Richter Plc.
-
It is used to treat osteoporosis in postmenopausal women and in men at risk of fracture. It is also used to treat bone loss caused by reduced hormone levels (testosterone) in patients with prostate cancer or by long-term use of glucocorticoids in people at risk of fracture.
Form: solution for injection
Active substance Dosage denosumab 60 mg/ml Manufacturer: Zentiva K.S.